LJCM
ABBV icon

Lee Johnson Capital Management’s AbbVie ABBV Stock Holding History

Lee Johnson Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,957
Closed -$1.77M – 17
2022
Q4 		$1.77M Buy
10,957
+510
+5% +$78.2K 3.3% 9
2022
Q3 		$1.4M Buy
10,447
+226
+2% +$32.4K 2.9% 13
2022
Q2 		$1.56M Buy
10,221
+654
+7% +$99.9K 1.86% 17
2022
Q1 		$1.55M Buy
9,567
+243
+3% +$35.3K 1.38% 28
2021
Q4 		$1.26M Buy
+9,324
New +$1.1M 1.04% 40

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Lee Johnson Capital Management's ABBV Position: Q1 2023 in Review

Lee Johnson Capital Management sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 10,957 shares — an estimated $1.77M sold.

Lee Johnson Capital Management first reported a position in ABBV in Q4 2021 and held it in 5 quarters. The position peaked at $1.77M in Q4 2022. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

  • Lee Johnson Capital Management reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
  • Lee Johnson Capital Management sold 10,957 AbbVie shares in Q1 2023, an estimated $1.77M.
  • Lee Johnson Capital Management first reported a position in AbbVie in Q4 2021 and held it in 5 quarters.
  • Lee Johnson Capital Management's AbbVie position peaked at $1.77M in Q4 2022.
  • 3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Lee Johnson Capital Management's 13F filing for Q1 2023, filed 11 Apr 2023.